Oxford Biodynamics PLC
LSE:OBD

Watchlist Manager
Oxford Biodynamics PLC Logo
Oxford Biodynamics PLC
LSE:OBD
Watchlist
Price: 0.3 GBX 7.14% Market Closed
Market Cap: 12.9m GBP

Operating Margin

-9.8%
Current
Improving
by 8.9%
vs 3-y average of -18.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-9.8%
=
Operating Income
£-10.7m
/
Revenue
£1.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-9.8%
=
Operating Income
GBX-10.7m
/
Revenue
£1.1m

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Oxford Biodynamics PLC
LSE:OBD
12m GBP
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
241B USD
Loading...
US
Danaher Corp
NYSE:DHR
170.9B USD
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.5B USD
Loading...
US
Waters Corp
NYSE:WAT
23.7B USD
Loading...

Market Distribution

Lower than 95% of companies in United Kingdom
Percentile
5th
Based on 3 579 companies
5th percentile
-9.8%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

Oxford Biodynamics PLC
Glance View

Oxford BioDynamics Plc is a biotechnology company, which engages in the discovery and development of novel epigenetic biomarkers for use within the pharmaceutical and biotechnology industry. The firm is engaged in advancing personalized healthcare by developing and commercializing medicine tests for life-changing diseases. The company has developed a three dimensional (3D) genomic biomarker platform, EpiSwitch, which builds molecular diagnostic classifiers for prediction of response to therapy, patient prognosis, disease diagnosis and subtyping, and residual disease monitoring in a range of indications. The platform discovers, evaluates, validates and monitors of biomarkers known as chromosome conformation signatures (CCSs). CCSs provides a compelling, stable framework from which changes in the regulation of a genome can be analyzed, long before the results of these epigenetic changes manifest themselves as obvious abnormalities. EpiSwitch supports precision medicine initiatives, including prediction of response to therapy, patient prognosis, disease diagnosis and subtyping, and residual disease monitoring.

OBD Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-9.8%
=
Operating Income
£-10.7m
/
Revenue
£1.1m
What is Oxford Biodynamics PLC's current Operating Margin?

The current Operating Margin for Oxford Biodynamics PLC is -9.8%, which is above its 3-year median of -18.7%.

How has Operating Margin changed over time?

Over the last 3 years, Oxford Biodynamics PLC’s Operating Margin has increased from -5 585.1% to -9.8%. During this period, it reached a low of -5 585.1% on Aug 30, 2022 and a high of -13.3% on Mar 31, 2025.

Back to Top